Correlation Between Reviva Pharmaceuticals and Agilent Technologies

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Agilent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Agilent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Agilent Technologies, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Agilent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Agilent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Agilent Technologies.

Diversification Opportunities for Reviva Pharmaceuticals and Agilent Technologies

0.06

Correlation Coefficient

Reviva Pharmaceuticals  Agilent Technologies

Significant diversification

The 3 months correlation between Reviva and Agilent is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Agilent Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agilent Technologies and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Agilent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agilent Technologies has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Agilent Technologies go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Agilent Technologies

Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to generate 41.35 times more return on investment than Agilent Technologies. However, Reviva Pharmaceuticals is 41.35 times more volatile than Agilent Technologies. It trades about 0.07 of its potential returns per unit of risk. Agilent Technologies is currently generating about 0.02 per unit of risk. If you would invest  112.00  in Reviva Pharmaceuticals Holdings on October 6, 2024 and sell it today you would lose (85.00) from holding Reviva Pharmaceuticals Holdings or give up 75.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Agilent Technologies

Reviva Pharmaceuticals

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Agilent Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Agilent Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Agilent Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Reviva Pharmaceuticals and Agilent Technologies

The main advantage of trading using opposite Reviva Pharmaceuticals and Agilent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Agilent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will offset losses from the drop in Agilent Technologies' long position.

The idea behind Reviva Pharmaceuticals Holdings and Agilent Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..